Clinical Trial Modernization: Decentralization, AI, and Data Quality

Multiple developments are reshaping clinical trials: decentralized trials boost rural enrollment (Mayo Clinic study), AI-driven monitoring shows $21M NPV per Phase III, data quality gaps threaten AI and RWE, and recruitment remains a bottleneck with 86% failure rate. Regulatory attention from FDA and HHS is increasing.